文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

针对接受辅助化疗的淋巴结阳性结直肠癌患者开发一种癌症特异性生存评估方法。

Development of a cancer-specific survival assessment for lymph node-positive colorectal cancer patients treated with adjuvant chemotherapy.

作者信息

Zhang Lei, Gao Shuang, Lin Xiaoyuan, Hu Junjie, Zhang Guolin, Tang Wei, Hu Yubo, Wang Yuanpeng, Chu Liang

机构信息

Department of General Surgery, The Second Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.

Graduate School of Bengbu Medical University, Bengbu, Anhui, China.

出版信息

Front Surg. 2025 May 12;12:1589875. doi: 10.3389/fsurg.2025.1589875. eCollection 2025.


DOI:10.3389/fsurg.2025.1589875
PMID:40421275
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12104235/
Abstract

BACKGROUND: To construct a prognostic model for predicting cancer-specific survival in lymph node-positive colorectal cancer patients treated with adjuvant chemotherapy after surgery. METHODS: Data were collected from the 2010-2015 SEER database and from CRC patients at the Second Affiliated Hospital of Bengbu Medical University (2017-2023). Lasso regression and random survival forest methods were used to screen ten clinicopathologic features. Cox regression analysis identified independent prognostic factors for CRC. Nomogram plot model was used to predict 1-, 3-, and 5-year survival rates, with its accuracy verified through ROC curves, calibration curves, and decision curve analysis (DCA). The X-tile software differentiated between high and low-risk groups and illustrated survival differences using Kaplan-Meier curves. RESULTS: Age, histologic grade, stage, CEA, nerve invasion, and LNR were independent prognostic risk factors for colorectal cancer ( < 0.001); and LNR were the five variables used to construct the Nomogram. The area under the curve (AUC) was 0.83, 0.85, and 0.84 at 1, 3, and 5 years for the training cohort; 0.83, 0.85, and 0.84 at 1, 3, and 5 years for the internal validation cohort; and 0.83, 0.85, and 0.84 at 1, 3, and 5 years for the external validation cohort, respectively. calibration curves, C-indexes, and DCA curves validated the accuracy of the model, respectively. The survival prognosis of the high-risk group was lower than that of the low-risk group in all three data sets. (HR = 6.37, CI:6.05-6.71,  < 0.05; HR = 7.05, CI:6.52-7.64,  < 0.05; HR = 2.69, CI:1.66-4.37,  < 0.05). CONCLUSIONS: LNR represents a new independent prognostic factor for lymph node-positive CRC. The optimal threshold determined by the Nomogram method effectively categorizes subgroups of lymph node-positive CRC cases after surgical chemotherapy, crucial for guiding clinical treatment strategy selection.

摘要

背景:构建一个预测术后接受辅助化疗的淋巴结阳性结直肠癌患者癌症特异性生存的预后模型。 方法:收集2010 - 2015年SEER数据库以及蚌埠医学院第二附属医院(2017 - 2023年)的结直肠癌患者数据。采用套索回归和随机生存森林方法筛选出10个临床病理特征。Cox回归分析确定结直肠癌的独立预后因素。使用列线图模型预测1年、3年和5年生存率,并通过ROC曲线、校准曲线和决策曲线分析(DCA)验证其准确性。X-tile软件区分高风险组和低风险组,并使用Kaplan-Meier曲线说明生存差异。 结果:年龄、组织学分级、分期、癌胚抗原(CEA)、神经侵犯和淋巴结转移率(LNR)是结直肠癌的独立预后危险因素(<0.001);LNR是用于构建列线图的5个变量。训练队列在1年、3年和5年时的曲线下面积(AUC)分别为0.83、0.85和0.84;内部验证队列在1年、3年和5年时分别为0.83、0.85和0.84;外部验证队列在1年、3年和5年时分别为0.83、0.85和0.84。校准曲线、C指数和DCA曲线分别验证了模型的准确性。在所有三个数据集中,高风险组的生存预后均低于低风险组(HR = 6.37,CI:6.05 - 6.71,<0.05;HR = 7.05,CI:6.52 - 7.64,<0.05;HR = 2.69,CI:1.66 - 并使用Kaplan-Meier曲线说明生存差异。 结果:年龄、组织学分级、分期、癌胚抗原(CEA)、神经侵犯和淋巴结转移率(LNR)是结直肠癌的独立预后危险因素(<0.001);LNR是用于构建列线图的5个变量。训练队列在1年、3年和5年时的曲线下面积(AUC)分别为0.83、0.85和0.84;内部验证队列在1年、3年和5年时分别为0.83、0.85和0.84;外部验证队列在1年、3年和5年时分别为0.83、0.85和0.84。校准曲线、C指数和DCA曲线分别验证了模型的准确性。在所有三个数据集中,高风险组的生存预后均低于低风险组(HR = 6.37,CI:6.05 - 6.71,<0.05;HR = 7.05,CI:6.52 - 7.64,<0.05;HR = 2.69,CI:1.66 - 4.37,<0.05)。 结论:LNR是淋巴结阳性结直肠癌的一个新的独立预后因素。通过列线图方法确定的最佳阈值有效地对手术化疗后淋巴结阳性结直肠癌病例的亚组进行了分类,这对于指导临床治疗策略的选择至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a4/12104235/cd94c5b752c1/fsurg-12-1589875-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a4/12104235/f9a99c228a12/fsurg-12-1589875-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a4/12104235/40c0bb68d149/fsurg-12-1589875-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a4/12104235/02f7d07c5c8e/fsurg-12-1589875-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a4/12104235/66106f3257fd/fsurg-12-1589875-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a4/12104235/f0ed77b488d6/fsurg-12-1589875-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a4/12104235/cd94c5b752c1/fsurg-12-1589875-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a4/12104235/f9a99c228a12/fsurg-12-1589875-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a4/12104235/40c0bb68d149/fsurg-12-1589875-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a4/12104235/02f7d07c5c8e/fsurg-12-1589875-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a4/12104235/66106f3257fd/fsurg-12-1589875-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a4/12104235/f0ed77b488d6/fsurg-12-1589875-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a4/12104235/cd94c5b752c1/fsurg-12-1589875-g006.jpg

相似文献

[1]
Development of a cancer-specific survival assessment for lymph node-positive colorectal cancer patients treated with adjuvant chemotherapy.

Front Surg. 2025-5-12

[2]
The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.

Front Endocrinol (Lausanne). 2023

[3]
Nomogram based on the log odds of negative lymph node/T stage can predict the prognosis of patients with colorectal cancer: a retrospective study based on SEER database and external validation in China.

BMJ Open. 2024-12-20

[4]
Evaluation of the association between lymph node ratio and long-term survival in patients after surgery for lymph node-positive bladder cancer: a SEER population-based study with external validation.

BMC Cancer. 2025-1-23

[5]
A survival nomogram model for patients with resectable non-small cell lung cancer and lymph node metastasis (N1 or N2) based on the Surveillance, Epidemiology, and End Results Database and single-center data.

Transl Lung Cancer Res. 2024-3-29

[6]
A Novel Prognostic Model and Practical Nomogram for Predicting the Outcomes of Colorectal Cancer: Based on Tumor Biomarkers and Log Odds of Positive Lymph Node Scheme.

Front Oncol. 2021-4-16

[7]
Constructing a prognostic model for colorectal cancer with synchronous liver metastases after preoperative chemotherapy: a study based on SEER and an external validation cohort.

Clin Transl Oncol. 2024-12

[8]
Prognostic value of tumor deposits and positive lymph node ratio in stage III colorectal cancer: a retrospective cohort study.

Int J Surg. 2024-6-1

[9]
Establishment of nomogram to predict overall survival and cancer-specific survival of local tumor resection in patients with colorectal cancer liver metastasis with unresectable metastases: a large population-based analysis.

Discov Oncol. 2024-7-29

[10]
A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.

Front Immunol. 2022

本文引用的文献

[1]
Neoadjuvant Immunotherapy Alone for Patients With Locally Advanced and Resectable Metastatic Colorectal Cancer of dMMR/MSI-H Status.

Dis Colon Rectum. 2024-11-1

[2]
Para-aortic Lymph Node Dissection for Colorectal Cancer: Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes.

Ann Surg Oncol. 2024-9

[3]
Effect of adjuvant radiotherapy on overall survival and breast cancer-specific survival of patients with malignant phyllodes tumor of the breast in different age groups: a retrospective observational study based on SEER.

Radiat Oncol. 2024-5-21

[4]
Predictors for lymph node metastasis and survival of patients with T1b esophageal adenocarcinoma treated with surgery and endoscopic therapy: an analysis of the Surveillance, Epidemiology, and End Results database.

Gastrointest Endosc. 2024-11

[5]
Tissue classification and diagnosis of colorectal cancer histopathology images using deep learning algorithms. Is the time ripe for clinical practice implementation?

Prz Gastroenterol. 2023

[6]
Prognostic value of tumor deposits and positive lymph node ratio in stage III colorectal cancer: a retrospective cohort study.

Int J Surg. 2024-6-1

[7]
Prognostic Value of Metastatic Lymph Node Ratio and Identification of Factors Influencing the Lymph Node Yield in Patients Undergoing Curative Colon Cancer Resection.

Cancers (Basel). 2024-1-2

[8]
Adjuvant chemotherapy in patients with clinically node-negative but pathologically node-positive rectal cancer in the Netherlands: A retrospective analysis.

Eur J Cancer. 2024-1

[9]
Personalizing adjuvant therapy for patients with colorectal cancer.

Nat Rev Clin Oncol. 2024-1

[10]
The role of deep learning in diagnosing colorectal cancer.

Prz Gastroenterol. 2023

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索